ORGANOGENESIS HOLDINGS INC. Deferred Tax Asset, Interest Carryforward
ORGANOGENESIS HOLDINGS INC. (ORGO) had Deferred Tax Asset, Interest Carryforward of $4.98 million as of 2020-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetInterestCarryforward · last filed 2022-03-01
- 2020-12-31: Deferred Tax Asset, Interest Carryforward $4.98M.
- 2019-12-31: Deferred Tax Asset, Interest Carryforward $7.03M.
| Period end | Deferred Tax Asset, Interest Carryforward |
|---|---|
| 2020-12-31 | $4.98M 10-K · filed 2022-03-01 |
| 2019-12-31 | $7.03M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |